David Martland is the Practice Group Leader of our M&A and Corporate Transactions practice group, which includes our internationally recognized Mergers & Acquisitions, Venture Capital and Sophisticated Business Transactions practices. David advises major strategics, investment funds and health care not-for-profits on acquisitions, investments and other significant transactions.
David was selected in 2017 by The Legal 500 as one of the 20 “Leading Lawyers” in Middle-Market M&A (sub $500 million) in the United States. He has also been recognized for exceptional standing in the legal community in Chambers USA: America’s Leading Lawyers for Business since 2006; in The Best Lawyers in America© since 2007 (Antitrust Law, Corporate Law, and Venture Capital Law); as a “recognized” lawyer in The Legal 500 U.S. since 2010; and, since 2007, as a “New England Super Lawyer,” based on peer review surveys by Boston Magazine. David also holds an AV Preeminent® Peer Review Rating™ from Martindale Hubbell®, the highest possible rating for ethics and legal ability, and is a winner of the International Law Office Client Choice Awards for M&A. The Client Choice awards recognize “law firms and partners around the world that stand apart for the excellent client care they provide and the quality of their service.”
David is co-chair of the TerraLex® strategic planning committee. TerraLex is a worldwide network of more than 155 leading independent law firms in 100 countries and 44 U.S. states, of which Nixon Peabody has been a member for over two decades.
David serves on the Boards of several cultural institutions. He is the chair of the Board of Trustees of Historic New England, a nonprofit organization dedicated to preserving New England buildings, landscapes and objects dating from the 17th century to the present.
David clerked for Walter R. Mansfield, United States Court of Appeals for the Second Circuit.
I counsel private and public companies and healthcare not-for-profits on the full range of corporate matters. I also represent a variety of private equity and venture funds in connection with their investments. In addition, I represent corporate and health care clients on antitrust matters.
The economy is growing and deal flow remains extremely high. Even with the change in administrations, the antitrust area will remain active with continued vigorous U.S. and international enforcement.
Food, Beverage & Agriculture Alert | 01.04.18
04.13.16 | Boston, MA
03.09.16 | New York, NY